HAVCR2 and systemic lupus erythematosus: A similar scenario was found for the expression of TIM-3, which was also higher on CD3+CD4+ (Figure 2(c)) and CD3+CD8+ T cell (Figure 2(d)) subsets in SLE patients, except that no difference was observed regarding anti-dsDNA antibodies positive or not.